H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
MSMbanner

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

Subclinical Rejection- a Potential Surrogate Marker for Chronic Rejection- May Be Diagnosed by Protocol Biopsy or Urine Spectroscopy

David Rush, Ray Somorjai, Roxanne Deslauriers, Anthony Shaw, John Jeffery, Peter Nickerson

Ann Transplant 2000; 5(2): 44-49

ID: 497525


Chronic renal transplant rejection is a major cause of late transplant failure. About 50% of graft losses after the first year are due to patient death with a functioning transplant. In the survivors, about 50% to 80% of grafts are lost due to chronic rejection [1]. The design of studies to decrease the incidence of chronic rejection is hampered by the very large number of patients and the long-term follow up required [2]. The identification of early surrogate biomarkers for chronic rejection is therefore of considerable interest.

Keywords: subclinical rejection, protocol biopsies, urine spectroskopy

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree